BPC 157 and the Brain-Gut Axis: A Review of Its Wide-Ranging Effects in Animal Models

This is a narrative review that compiles and synthesizes findings from the Sikiric research group's own published animal studies on BPC 157. It presents results from various rat and animal models across multiple organ systems. No new experimental data is presented, and the review primarily draws from the authors' own body of work.

BPC 157 is one of the most widely discussed peptides in the research peptide community, yet virtually all published data comes from a single research group. This review is significant because it represents the most comprehensive summary of BPC 157's proposed mechanisms from its primary investigators, but readers should note the lack of independent replication and the absence of human clinical trial data.

BPC 157 occupies an unusual position in peptide research — it has an extensive preclinical literature from primarily one research group but almost no independent replication or human clinical trials. This review attempts to unify the diverse animal findings under a brain-gut axis framework. The gap between the breadth of claimed effects in animals and the absence of human data remains the central challenge in evaluating BPC 157's therapeutic potential.

This review draws almost exclusively from the authors' own research, raising concerns about independent verification. All evidence comes from animal models — no human clinical trials are cited. The extraordinary breadth of claimed effects (behavioral, cardiovascular, muscular, hepatic, renal, gastrointestinal) from a single peptide is unusual and warrants independent confirmation. The narrative review format does not apply systematic methodology for evaluating evidence quality.